Rev. Dr. Ronald E. Avery

Rev. Dr. Ronald E. Avery

Senior Pastor

Senior Pastor

St. Matthew Baptist Church

Rev. Dr. Ronald E. Avery is married to First Lady Addie M. Avery. They are spirituality-led and God-fearing people. They have one son, Reverend Roderick Avery, a daughter-in-law, Reverend Charlotte Avery, and seven beautiful grandchildren.

In June 1980, Dr. Avery answered God’s call to become a minister. Pastor Avery preached his initial sermon at his home church, Wake Baptist Grove, in Garner, North Carolina. He earned a Doctor of Divinity from Newburgh Theological Seminary in Newburgh, Indiana. Also, he earned a Master of Divinity from Shaw University. Since assuming the pastorate of St. Matthew Baptist Church in March 1981, Pastor Avery has devoted himself to building God’s Kingdom through many relative ministries and programs.  He served as the Moderator of the Wake Baptist Missionary Association (WMBA) from 2007 to 2010.

Under the leadership of Pastor Avery, the St. Matthew Baptist Church has grown physically and spiritually. His vision is to inspire a ministry that will be applicable to 21st-century needs and give a better understanding of the work of the invisible church. Pastor Avery has dedicated his life to serving God and His people from generation to generation.  As the St. Matthew Baptist Church moves toward the 21st century, Pastor Avery has God’s given vision to continue to give God all glory as he uses new technology to spread the Word to those of all ages.

Dr. Edith Mitchell

Dr. Edith Mitchell

Enterprise Associate Director for Cancer Disparities

Enterprise Associate Director for Cancer Disparities

Sidney Kimmel Medical Center at Jefferson Health

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP, is Board Certified in Internal Medicine and Medical Oncology and is Clinical Professor, Department of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for the Sidney Kimmel Cancer Center at Thomas Jefferson University.  Dr. Mitchell has spent her medical career helping individuals in medically underserved areas to realize that simple changes in lifestyle can have a dramatic impact on cancer care. Through her work, Dr. Mitchell has demonstrated the importance of community service and outreach, especially to those individuals who may not have the means to seek out more conventional medical advice.

Dr. Mitchell received a Bachelor of Science in Biochemistry “with distinction” from Tennessee State University and her medical degree from the Medical College of Virginia in Richmond. In 1973, while attending medical school, Dr. Mitchell entered the Air Force and received a commission through the Health Professions Scholarship Program. She entered active duty after completion of her internship and residency in Internal Medicine at Meharry Medical College and a fellowship in Medical Oncology at Georgetown University.

Dr. Mitchell’s research in breast, colorectal, and pancreatic cancers and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined modality therapy, patient selection criteria and supportive care for patients with gastrointestinal cancer. She travels nationally and internationally teaching and lecturing on the treatment of gastrointestinal malignancies.

Dr. Mitchell has authored and co-authored more than 150 articles and book chapters as well as many abstracts on cancer treatment, prevention, and cancer control. As a distinguished researcher, she has received many Cancer Research and Principal Investigator Awards including a recent Promise Grant from the Susan G. Komen Foundation. She serves on the National Cancer Institute Review Panel and the Cancer Investigations Review Committee, the Clinical Trials and Translational Research Advisory Committee, and is Co-Chair of the NCI Disparities Committee, and a member of the NIH Council of Councils. Because of her experience in the cancer research community, Dr. Mitchell was selected to serve as a member of the NCI’s Blue Ribbon Panel convened to advise the National Cancer Advisory Board on Vice President Biden’s National Cancer Moonshot Initiative. In 2019, Dr. Mitchell began service as a member of the President’s Cancer Panel, and, in 2020, she became a Fellow of the Royal College of Physicians.

Dr. Mitchell holds leadership positions in the American Society of Clinical Oncology and was the 116th President of the National Medical Association, serving from August 2015 to August 2016. She also serves on the editorial board of the Journal of the National Medical Association, and is a Board member of the Museum of the American Revolution, and the Board of Trustees for Geisinger Commonwealth Medical College and Tennessee State University.

Among her many honors, Dr. Mitchell has received the ‘Tree of Life’ Award, which recognizes health professionals who have made extraordinary contributions to health management in both the local and global community. Dr. Mitchell was awarded the American Cancer Society’s Cancer Control Award for her significant commitment to research, education, and diversity and the Research Award by the Council of Women Physicians of The National Medical Association.  In 2010, she received the National Cancer Care Physician of the Year Award in recognition of her outstanding contribution of time and talent. Other awards for Dr. Mitchell include the 2009 Looking Glass Award presented by the Living with Cancer Foundation and the Women in Medicine Research Award from the National Medical Association. She received the 2011 Practitioner of the Year Award by the Philadelphia County Medical Society and the 2012 Humanitarian Practitioner of the Year Award by the American Society of Clinical Oncology. In 2013, she received the Lifetime Achievement Award from Alpha Kappa Alpha Sorority, Inc., was inducted into the National Historical Black College Hall of Fame and also received the Octavius Valentine Catto Award for community service in the City of Philadelphia from the Mann Center. In 2015, she received the Medical Tree of Life Award from Debbie’s Dream Foundation: Curing Stomach Cancer. In 2016, Dr. Mitchell was selected as the Historically Black College Alumnus of the Year. In 2017, Dr. Mitchell was inducted as an Honorary Member of the American Society for Radiation Oncology. In 2018, she received the Edith P. Wright Breast Cancer Foundation Eydie’s Angels Loving Hands Service Award and the Jefferson Health Achievement Award in Medicine and in 2019, the Ultimate Solution Award from Philadelphia Life Sciences, the Distinguished Citizen Award from Kappa Alpha Psi Fraternity, Inc., and was honored by the Geisinger Commonwealth School of Medicine with their Well-Being Award. In 2020, she was an honoree for the United Negro College Fund’s Mayor’s Masked Ball. Most recently, she was selected as the 2021 Tennessee State University Black History Month Alumni Honoree and the recipient of the AACR-Minorities in Cancer Research Jane Cooke Wright Lectureship Award.

In addition to her medical achievements, Dr. Mitchell is a retired United States Air Force  Brigadier General, having served as the Air National Guard Assistant to the Command Surgeon for US Transportation command and headquarters Air Mobility Command (AMC) based at the Scott Air Force Base in Illinois. General Mitchell has been awarded over 15 military service medals and ribbons including the Legion of Merit, Meritorious Service Medal, Air Force Achievement and Commendation Medals, National Defense Service Medal, and Humanitarian Service Medal. Dr. Mitchell was selected for inclusion in America’s Top Oncologists. Dr. Mitchell is a Master of the American College of Physicians, a Fellow of the College of Physicians of Philadelphia, and member of the American Medical Association, the National Medical Association, Aerospace Medical Association, Association of Military Surgeons, the Medical Society of Eastern Pennsylvania, the ECOG/ACRIN Cancer Research Group, and the Radiation Therapy Oncology Group.

On a personal note, Dr. Mitchell enjoys gardening, quilting, listening to jazz and rock music, and spending time with her family. She and husband Delmar have been married over fifty years and have two daughters, Dale and DeAnna, two granddaughters, Gabriella and Lilly, and two grandsons, Jude and Luke.

Dr. Curtis A. Pettaway

Dr. Curtis A. Pettaway

Professor, Department of Urology

Professor, Department of Urology

MD Anderson Cancer Center

Dr. Curtis Pettaway is a Professor of Urology at The University of Texas MD Anderson Cancer Center in Houston, Texas. His clinical practice is based on treating patients with genitourinary malignancies, including penile, urethral, and prostate malignancies. The goals of his prostate-related studies are to further define the host and molecular markers of cancer progression and to reduce disparities in prostate cancer outcomes among African Americans and the underserved by studying both the clinical and biological correlates of aggressive disease.

He has served as the Medical Director of the Prostate Outreach Project (POP), an initiative that has educated and screened more than 5,000 men. Dr. Pettaway has also served as the Co-Director of a National Cancer Institute-funded study evaluating the influence of West African ancestry on the incidence and aggressiveness of prostate cancer among African American and Puerto Rican populations.

Dr. Daniel Barocas

Dr. Daniel Barocas

Professor, Department of Urology

Professor, Department of Urology

Vanderbilt University Medical Center

Dr. Daniel Barocas is an accomplished researcher who focuses on quality of life, quality of care, healthcare disparities, and comparative effectiveness. He is the principal investigator of a multi-center study on the effectiveness and side effects of different treatments for prostate cancer.

Dr. Simpa Salami

Dr. Simpa Salami

Assistant Professor, Urology

Assistant Professor, Urology

University of Michigan Health Michigan Medicine

Simpa S. Salami, M.D., M.P.H., is a fellowship-trained, board-certified Urologic Oncologist and Associate Professor of Urology at the University of Michigan. He obtained his MD from the College of Medicine, University of Ibadan, Nigeria. He completed a Master of Public Health program at Harvard University, a General Surgery Internship at the Brigham and Women’s Hospital in Boston, Urology Residency at Hofstra Northwell Health School of Medicine in New York, and a Urologic Oncology Fellowship at the University of Michigan in Ann Arbor, Michigan. Dr. Salami is a translational surgeon-scientist whose research interests are in early detection and staging of prostate and kidney cancer. The goal of his research is to develop novel cancer biomarkers to overcome tumor heterogeneity and multifocality as well as elucidate optimal paradigms for early detection of urologic cancers, risk stratification, prognostication, and prediction of treatment response.  Dr. Salami is a recipient of numerous awards including the: Harvard University Presidential Scholar, Prostate Cancer Foundation Young Investigator, American Urological Association (AUA) Urology Care Foundation (UCF) Research Scholar, AUA UCF Rising Stars in Urologic Research, Harold Amos Medical Faculty Development Fellowship, Rogel Cancer Center Scholar, and Society of Urologic Oncology Young Investigator Awards. He has served on several National guideline committees, such as the AUA Prostate Cancer Early Detection Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, and the Society of Nuclear Medicine and Imaging PSMA PET Appropriate Use Criteria Working Group. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation.

Dr. Yaw Nyame

Dr. Yaw Nyame

Assistant Professor and OCOE Program Lead, Department of Urology

Assistant Professor and OCOE Program Lead, Department of Urology

Fred Hutchinson Cancer Center, University of Washington

Dr. Yaw Nyame attended medical school at the Feinberg School of Medicine at Northwestern University and business school at the Kellogg School of Management at Northwestern University, graduating in 2012. Prior to medical school, he completed a Master’s Degree in Health Services and Administration at the School of Public Health at George Washington University.

Dr. Nyame completed his general surgery internship and urology residency training at the Glickman Urological and Kidney Institute at the Cleveland Clinic. He came to the Northwest to complete a Society of Urologic Oncology accredited fellowship at the University of Washington and joined the faculty upon completing his training.

Dr. Nyame has a research interest in health disparities in urologic cancers with a focus on using patient-centered approaches to build translational health services as well as molecular and clinical solutions to health inequities in prostate cancer and other urologic malignancies.